| Jennifer C Moshman, MD | |
|
1000 N Providence Dr Ste 120, Newberg, OR 97132-7582 | |
| (503) 537-5900 | |
| Not Available |
| Full Name | Jennifer C Moshman |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 6 Years |
| Location | 1000 N Providence Dr Ste 120, Newberg, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194212092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD203422 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Home Health | Portland, OR | Home health agency |
| Providence Newberg Medical Center | Newberg, OR | Hospital |
| Providence Portland Medical Center | Portland, OR | Hospital |
| Willamette Valley Medical Center | Mcminnville, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
The WHO FCTC has become one of the most rapidly embraced United Nations' conventions, with 167 WHO Member States and the European Community (EC) signing, and 23 countries ratifying, accepting, approving or acceding to the Convention, just one year after it opened for signature in Geneva.
In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options.
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
The WHO FCTC has become one of the most rapidly embraced United Nations' conventions, with 167 WHO Member States and the European Community (EC) signing, and 23 countries ratifying, accepting, approving or acceding to the Convention, just one year after it opened for signature in Geneva.
In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options.
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952482275 PECOS PAC ID: 3072415652 Enrollment ID: O20040123000519 |
News Archive
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
The WHO FCTC has become one of the most rapidly embraced United Nations' conventions, with 167 WHO Member States and the European Community (EC) signing, and 23 countries ratifying, accepting, approving or acceding to the Convention, just one year after it opened for signature in Geneva.
In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options.
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer C Moshman, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Jennifer C Moshman, MD 1000 N Providence Dr Ste 120, Newberg, OR 97132-7582 Ph: (503) 537-5900 |
News Archive
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
The WHO FCTC has become one of the most rapidly embraced United Nations' conventions, with 167 WHO Member States and the European Community (EC) signing, and 23 countries ratifying, accepting, approving or acceding to the Convention, just one year after it opened for signature in Geneva.
In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient's best treatment options.
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat. Scientists at multiple institutions have found a new way of classifying brain cancers that could very well change how the illness is diagnosed and treated.
› Verified 2 days ago
James Lewis Miller, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1001 N Providence Dr, Newberg, OR 97132 Phone: 503-537-5607 | |
Lohith Veerappa Reddy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 N Providence Dr, Newberg, OR 97132 Phone: 503-537-5607 | |
Elizabeth S Severson, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1000 N Providence Dr Ste 120, Newberg, OR 97132 Phone: 503-537-5900 | |
Sean M Stadtlander, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1003 Providence Dr, Suite 210, Newberg, OR 97132 Phone: 503-537-5900 Fax: 503-537-5959 | |
Kristina Brittany Moon, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 N Providence Dr Ste 325, Newberg, OR 97132 Phone: 503-537-6026 Fax: 503-537-6027 | |
Dr. Lian R Shaw, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1003 Providence Dr, Suite 325, Newberg, OR 97132 Phone: 503-216-2188 | |
Theodore Allen Foster Iii, D.O., M.P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1003 Providence Dr Ste 325, Newberg, OR 97132 Phone: 503-537-6026 |